Many of the studies being conducted to prolong the life of dogs may eventually be applied to a human version of the same medication.
Because humans and dogs share many age-related diseases, live in many of the same environments, and have many of the same habits because our lives are so intertwined.
According to The Guardian, Loyal founder and CEO Celine Halioua stated, “Determining how to prevent canine age-related decline is a really strong proxy for doing.
The same with humans because dogs get similar age-related diseases and share our environments and habits in ways laboratory mice do not.”
In the meanwhile, a completely separate group of scientists from the Dog Ageing Project at the University of Washington.
